BioCentury | Jul 28, 2016
Finance

MRCT looks east

...the most active at creating relationships in Asia. In 2014, MRCT signed development deals with Yabao Pharmaceutical Group Co. Ltd....
...Administration (FDA) , Silver Spring, Md. Wellcome Trust, London, U.K. Wired Differently Inc., Boston, Mass. Yabao Pharmaceutical Group Co. Ltd....
BioCentury | Apr 25, 2016
Company News

Salus, Yabao Pharmaceutical Group deal

...U.S. rights. Salus declined to disclose additional details. Salus Pharma LLC , Monmouth Junction, N.J. Yabao Pharmaceutical Group Co. Ltd....
BioCentury | Apr 22, 2016
Company News

Yabao, Salus partner in complex generics

Yabao Pharmaceutical Group Co. Ltd. (Shanghai:600351) partnered with Salus Pharma LLC (Monmouth Junction, N.J.) to develop, manufacture and commercialize complex formulations of generics. Yabao will hold exclusive ex-U.S. commercialization rights for certain Salus-developed products, while...
BioCentury | Dec 17, 2015
Distillery Therapeutics

Therapeutics: Suppressor of cytokine signaling 3 (SOCS3); phosphatase and tensin homolog deleted on chromosome ten (PTEN; MMAC1; TEP1)

...SOCS3 and PTEN in tissue samples from patients with nerve damage. Primary Peptides Inc. and Yabao Pharmaceutical Group Co. Ltd....
BioCentury | Oct 26, 2015
Company News

Eli Lilly, Yabao Pharmaceutical Group deal

...the candidate. Lilly did not respond to inquiries. Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. Yabao Pharmaceutical Group Co. Ltd....
BioCentury | Oct 21, 2015
Company News

Yabao gets Chinese license to Lilly's SGLT1 program

Yabao Pharmaceutical Group Co. Ltd. (Shanghai:600351) partnered with Eli Lilly and Co. (NYSE:LLY) to co-develop a sodium-glucose cotransporter 1 ( SGLT1 ) inhibitor to treat diabetes. Yabao said the program has completed a Phase I study in...
BioCentury | Oct 12, 2015
Company News

Yabao Pharmaceutical Group, University of South Australia deal

...university will retain rights in all other regions. The partners declined to disclose financial terms. Yabao Pharmaceutical Group Co. Ltd....
BioCentury | Oct 12, 2015
Company News

Primary Peptides, Yabao Pharmaceutical Group deal

...in China. The companies declined to disclose financial terms. Primary Peptides Inc. , Vancouver, B.C. Yabao Pharmaceutical Group Co. Ltd....
BioCentury | Jun 8, 2015
Emerging Company Profile

Financing innovation in China

...Nanjing, China University of South Australia, Adelaide, South Australia WuXi PharmaTech Inc. (NYSE:WX), Shanghai, China Yabao Pharmaceutical Group Co. Ltd....
...Yabao Pharmaceutical Group Co. Ltd. , Eli Lilly and Co. Number of employees: 21 Funds raised: Not disclosed Investors: Yabao Pharmaceutical Group Co. Ltd....
BioCentury | Dec 18, 2014
Translation in Brief

YABAO GOES BOLD

...Yabao goes bold China-based Yabao Pharmaceutical Group Co. Ltd. and MRC Technology are jointly going where Western pharmas and academics...
...Singapore Thermo Fisher Scientific Inc. (NYSE:TMO), Waltham, Mass. WuXi PharmaTech Inc. (NYSE:WX) Shanghai, China Yabao Pharmaceutical Group Co. Ltd....
...in clinical trials. MRC Technology also announced a separate licensing and R&D deal with China-based Yabao Pharmaceutical Group Co. Ltd....
Items per page:
1 - 10 of 13
BioCentury | Jul 28, 2016
Finance

MRCT looks east

...the most active at creating relationships in Asia. In 2014, MRCT signed development deals with Yabao Pharmaceutical Group Co. Ltd....
...Administration (FDA) , Silver Spring, Md. Wellcome Trust, London, U.K. Wired Differently Inc., Boston, Mass. Yabao Pharmaceutical Group Co. Ltd....
BioCentury | Apr 25, 2016
Company News

Salus, Yabao Pharmaceutical Group deal

...U.S. rights. Salus declined to disclose additional details. Salus Pharma LLC , Monmouth Junction, N.J. Yabao Pharmaceutical Group Co. Ltd....
BioCentury | Apr 22, 2016
Company News

Yabao, Salus partner in complex generics

Yabao Pharmaceutical Group Co. Ltd. (Shanghai:600351) partnered with Salus Pharma LLC (Monmouth Junction, N.J.) to develop, manufacture and commercialize complex formulations of generics. Yabao will hold exclusive ex-U.S. commercialization rights for certain Salus-developed products, while...
BioCentury | Dec 17, 2015
Distillery Therapeutics

Therapeutics: Suppressor of cytokine signaling 3 (SOCS3); phosphatase and tensin homolog deleted on chromosome ten (PTEN; MMAC1; TEP1)

...SOCS3 and PTEN in tissue samples from patients with nerve damage. Primary Peptides Inc. and Yabao Pharmaceutical Group Co. Ltd....
BioCentury | Oct 26, 2015
Company News

Eli Lilly, Yabao Pharmaceutical Group deal

...the candidate. Lilly did not respond to inquiries. Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. Yabao Pharmaceutical Group Co. Ltd....
BioCentury | Oct 21, 2015
Company News

Yabao gets Chinese license to Lilly's SGLT1 program

Yabao Pharmaceutical Group Co. Ltd. (Shanghai:600351) partnered with Eli Lilly and Co. (NYSE:LLY) to co-develop a sodium-glucose cotransporter 1 ( SGLT1 ) inhibitor to treat diabetes. Yabao said the program has completed a Phase I study in...
BioCentury | Oct 12, 2015
Company News

Yabao Pharmaceutical Group, University of South Australia deal

...university will retain rights in all other regions. The partners declined to disclose financial terms. Yabao Pharmaceutical Group Co. Ltd....
BioCentury | Oct 12, 2015
Company News

Primary Peptides, Yabao Pharmaceutical Group deal

...in China. The companies declined to disclose financial terms. Primary Peptides Inc. , Vancouver, B.C. Yabao Pharmaceutical Group Co. Ltd....
BioCentury | Jun 8, 2015
Emerging Company Profile

Financing innovation in China

...Nanjing, China University of South Australia, Adelaide, South Australia WuXi PharmaTech Inc. (NYSE:WX), Shanghai, China Yabao Pharmaceutical Group Co. Ltd....
...Yabao Pharmaceutical Group Co. Ltd. , Eli Lilly and Co. Number of employees: 21 Funds raised: Not disclosed Investors: Yabao Pharmaceutical Group Co. Ltd....
BioCentury | Dec 18, 2014
Translation in Brief

YABAO GOES BOLD

...Yabao goes bold China-based Yabao Pharmaceutical Group Co. Ltd. and MRC Technology are jointly going where Western pharmas and academics...
...Singapore Thermo Fisher Scientific Inc. (NYSE:TMO), Waltham, Mass. WuXi PharmaTech Inc. (NYSE:WX) Shanghai, China Yabao Pharmaceutical Group Co. Ltd....
...in clinical trials. MRC Technology also announced a separate licensing and R&D deal with China-based Yabao Pharmaceutical Group Co. Ltd....
Items per page:
1 - 10 of 13